Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Handheld Biosensor for COVID-19 Screening

Technical Report ·
DOI:https://doi.org/10.2172/1671376· OSTI ID:1671376
 [1];  [1];  [1]
  1. Sandia National Laboratories (SNL), Albuquerque, NM, and Livermore, CA (United States)

We have made significant progress toward the development of an integrated nucleic acid amplification system for Autonomous Medical Devices Incorporated (AMDIs) Optikus handheld diagnostic device. In this effort, we developed a set of loop-mediated isothermal amplification (LAMP) primers for SARS-CoV-2 and then demonstrate amplification directly on a surface acoustic wave (SAW) sensor. We built associated hardware and developed a C-code to control the amplification process. The goal of this project was to develop a nucleic amplification assay that is compatible with SAW sensors to enable both nucleic and serological testing in a single handheld diagnostic device. Toward this goal, AMDI is collaborating Sandia National Laboratories to develop a rapid, portable diagnostic screening device that utilizes Sandias unique surface acoustic wave biosensor (SAW) for COVID-19 detection. Previously, the SANDIA- AMDI SAW sensor has successfully detected multiple high-profile bacteria viruses, including Ebola, HIV, Sin Nombre, and Anthrax. Over the last two years, AMDI and SANDIA have significantly improved the sensitivity and detection capability of the SAW biosensor and have also developed a modular hand-held, portable platform called the Optikus, which uses CD microfluidics and handheld instrumentation to automate all sample preparation, reagent introduction, sample delivery, and measurement for a number of different assay targets. We propose to use this platform for the development of a rapid (%3C30 minutes), point-of-care diagnostic test for detection of COVID-19 from nasal swab samples.

Research Organization:
Sandia National Laboratories (SNL-NM), Albuquerque, NM (United States)
Sponsoring Organization:
USDOE National Nuclear Security Administration (NNSA)
DOE Contract Number:
AC04-94AL85000; NA0003525
OSTI ID:
1671376
Report Number(s):
SAND--2020-10358; 691211
Country of Publication:
United States
Language:
English

Similar Records

Rapid detection of Ebola virus with a reagent-free, point-of-care biosensor
Journal Article · Tue Apr 14 00:00:00 EDT 2015 · Sensors · OSTI ID:1213407

Reveal-CoV Diaagnostic Platform (Final Report)
Technical Report · Thu May 13 20:00:00 EDT 2021 · OSTI ID:2530263

A Handheld Medical Diagnostic Device for Harsh Environments
Technical Report · Tue Nov 12 23:00:00 EST 2019 · OSTI ID:1574630